AIDS (London, England) · 2025
The impact of the COVID-19 and mpox outbreaks on behaviours associated with HCV infection among MSM: results from the prerandomisation phase of a clinical trial.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Hage Kris, Boyd Anders, Davidovich Udi, Generaal Ellen, Hoornenborg Elske, Zantkuijl Paul, van der Valk Marc, Verhagen Dominique, Stalenhoef Janneke, Hollander Jan den, Leyten Eliane, Mudrikova Tania, Rougier Hayette, Chiarabini Thibault, Valantin Marc-Antoine, Pialoux Gilles, Campa Pauline, Schinkel Janke, Lacombe Karine, Prins Maria, ICECREAM study group
Аннотация
OBJECTIVE: To assess whether the COVID-19 and mpox outbreaks affected hepatitis C virus (HCV) related behaviours among men who have sex with men (MSM) with a cleared HCV infection.
DESIGN: Longitudinal analysis from the international ICECREAM trial (2021-2024).
METHODS: During the prerandomisation phase (i.e., without any intervention) individuals completed questionnaires on sexual and drug use behaviours and whether the COVID-19 (since start trial) or mpox (shortly after the mpox outbreak in 2022) outbreaks caused changes in these behaviours, all referring to the preceding 6 months. We used mixed-effects logistic regression to model changes in behaviours due to COVID-19 or mpox measures and mixed-effects linear regression to model the average HCV-MOSAIC risk score, as a proxy of HCV-associated risk behaviour, over calendar time.
RESULTS: 220 MSM ( n = 117 from the Netherlands, n = 103 from France) were included. Among 208 that completed the baseline questionnaire, 171 (82.2%) were MSM with HIV. The proportion of individuals reporting any impact of COVID-19 restrictions on risk behaviours, mainly lowering number of partners, decreased from 74.7% in September 2021 to 6.7% in September 2024 ( P < 0.001) and reporting any impact of mpox from 41.9% in November 2022 to 6.0% in September 2024 ( P = 0.001). The average HCV-MOSAIC risk score remained constant over time ( P = 0.59) and was consistently ≥2.0, indicating high reinfection susceptibility.
CONCLUSION: HCV-related behaviours decreased when COVID-19 and mpox measures were in place. However, individuals still engaged in behaviours associated with HCV, highlighting the importance of continued sexual health services and prevention efforts during such outbreaks.
DESIGN: Longitudinal analysis from the international ICECREAM trial (2021-2024).
METHODS: During the prerandomisation phase (i.e., without any intervention) individuals completed questionnaires on sexual and drug use behaviours and whether the COVID-19 (since start trial) or mpox (shortly after the mpox outbreak in 2022) outbreaks caused changes in these behaviours, all referring to the preceding 6 months. We used mixed-effects logistic regression to model changes in behaviours due to COVID-19 or mpox measures and mixed-effects linear regression to model the average HCV-MOSAIC risk score, as a proxy of HCV-associated risk behaviour, over calendar time.
RESULTS: 220 MSM ( n = 117 from the Netherlands, n = 103 from France) were included. Among 208 that completed the baseline questionnaire, 171 (82.2%) were MSM with HIV. The proportion of individuals reporting any impact of COVID-19 restrictions on risk behaviours, mainly lowering number of partners, decreased from 74.7% in September 2021 to 6.7% in September 2024 ( P < 0.001) and reporting any impact of mpox from 41.9% in November 2022 to 6.0% in September 2024 ( P = 0.001). The average HCV-MOSAIC risk score remained constant over time ( P = 0.59) and was consistently ≥2.0, indicating high reinfection susceptibility.
CONCLUSION: HCV-related behaviours decreased when COVID-19 and mpox measures were in place. However, individuals still engaged in behaviours associated with HCV, highlighting the importance of continued sexual health services and prevention efforts during such outbreaks.